Disease: Coronary Artery Disease ×
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2681492
rs2681492
Entrez Id: 490
Gene Symbol: ATP2B1
ATP2B1
CUI: C1956346
Disease:
Coronary Artery Disease 		T 0.700 GeneticVariation GWASCAT Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease. 29212778 2018
dbSNP: rs57481061
rs57481061
Entrez Id: 490
Gene Symbol: ATP2B1
ATP2B1
CUI: C1956346
Disease:
Coronary Artery Disease 		C 0.700 GeneticVariation GWASCAT Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease. 29212778 2018
dbSNP: rs2681472
rs2681472
Entrez Id: 490
Gene Symbol: ATP2B1
ATP2B1
CUI: C1956346
Disease:
Coronary Artery Disease 		G 0.700 GeneticVariation GWASCAT Association analyses based on false discovery rate implicate new loci for coronary artery disease. 28714975 2017
dbSNP: rs2681472
rs2681472
Entrez Id: 490
Gene Symbol: ATP2B1
ATP2B1
CUI: C1956346
Disease:
Coronary Artery Disease 		G 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387 2015
dbSNP: rs12818945
rs12818945
Entrez Id: 490
Gene Symbol: ATP2B1
ATP2B1
CUI: C1956346
Disease:
Coronary Artery Disease 		0.010 GeneticVariation BEFREE However, SNP rs2301753 on chromosome 6 in RNF39 was associated with reduced likelihood of nonobstructive CAD [odds ratio (OR) 0.42 and 95% confidence interval (CI) of 0.29 to 0.68], at a nominal level of P = 5.6 × 10(-6), while SNP rs12818945 in the ATP2B1 locus on chromosome 12 was associated with increased odds for nonobstructive CAD (OR 2.38 and 95% CI of 1.63 to 3.45) and nominal P = 5.8 × 10(-6). 26534935 2016
dbSNP: rs12817819
rs12817819
Entrez Id: 490
Gene Symbol: ATP2B1
ATP2B1
CUI: C1956346
Disease:
Coronary Artery Disease 		0.010 GeneticVariation BEFREE The ATP2B1 rs12817819 A allele is associated with increased risk for RHTN in hypertensive participants with documented CAD or suspected ischemic heart disease. 25385345 2014